Venous thromboembolism (VTE) is often associated with malignant diseases and notably
contributes to morbidity and mortality in patients with cancer. Cancer‐associated thrombosis …

Simple Summary Historically, patients with pancreatic ductal adenoma carcinoma were
subjected to immediate surgical resection of the pancreatic tumor. Nowadays, more and …

Cancer-associated venous thromboembolism (VTE) is a major source of oncologic cost,
morbidity and mortality. Identifying high-risk patients for prophylactic anticoagulation is …

Background Guidelines recommend thromboprophylaxis for patients with cancer at high risk
of venous thromboembolism (VTE). Polygenic risk scores may improve VTE prediction but …

Background Venous thromboembolism is the leading cause of death in cancer patients,
second only to tumor progression. The Khorana score is recommended by clinical …

PURPOSE Recent studies have suggested that machine learning (ML) could be used to
predict venous thromboembolism (VTE) in cancer patients with high accuracy. METHODS …

Abstract The Spanish Society of Medical Oncology (SEOM) last published clinical guidelines
on venous thromboembolism (VTE) and cancer in 2019, with a partial update in 2020. In this …

Simple Summary Cancer patients are at greater risk of developing venous
thromboembolism compared to the general population, which can lead to a decreased …

Objective To compare the venous thromboembolism (VTE) rate in patients with ovarian
cancer undergoing neoadjuvant chemotherapy before and after implementing routine …

In thrombotic diseases, coagulation, anticoagulation, and fibrinolysis are three key
physiological processes that interact to maintain blood in an appropriate state within blood …